Staphylococcus aureus and Dairy Udder

A. I. Aqib, M. Ijaz, M. Shoaib, I. Muzammil, H. I. Hussain, Tean Zaheer, R. Ahmed, Iqra Sarwar, Y. Khan, M. Naseer
{"title":"Staphylococcus aureus and Dairy Udder","authors":"A. I. Aqib, M. Ijaz, M. Shoaib, I. Muzammil, H. I. Hussain, Tean Zaheer, R. Ahmed, Iqra Sarwar, Y. Khan, M. Naseer","doi":"10.5772/INTECHOPEN.95864","DOIUrl":null,"url":null,"abstract":"Staphylococcus aureus is a major causative agent of intra-mammary infections in dairy animals with potential virulence of surface components, toxins, and extracellular enzymes. About 74% quarter prevalence of S. aureus in bovine udder with overall prevalence exceeding 61% in dairy animals. About 17 different serotypes of dairy originated S. aureus have been reported with 24 virulence coding genes for leukocidins (lukED/lukM), pyrogenic toxin super antigen (PTSAg), haemolysins (hla-hlg), toxic-shock syndrome toxin (tst), enterotoxins (sea-seo, seu), exfoliative toxins (eta, etb), and genes for methicillin (mecA) and penicillin (blaZ) resistance. Attainment of refuge inside the macrophages and neutrophils is a major cause of S. aureus mastitis persistence. Mammary prebiotics and probiotics are recently being used as alternatives to antibiotic for the prevention of mastitis. Literature showed anti- staphylococcus vaccines with different results depending upon types of immunization, route of administration and adjuvant used. Studies has shown that herd specific as well as commercial S. aureus vaccines reduce new infections in dairy animals. Experiments are still in progress for the use of vaccines against S. aureus mastitis with optimal efficacy and reliability. Perhaps, there might be bright future because of highly satisfactory trial results of mastitis vaccines in the lab animals.","PeriodicalId":260041,"journal":{"name":"Staphylococcus aureus [Working Title]","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Staphylococcus aureus [Working Title]","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.95864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Staphylococcus aureus is a major causative agent of intra-mammary infections in dairy animals with potential virulence of surface components, toxins, and extracellular enzymes. About 74% quarter prevalence of S. aureus in bovine udder with overall prevalence exceeding 61% in dairy animals. About 17 different serotypes of dairy originated S. aureus have been reported with 24 virulence coding genes for leukocidins (lukED/lukM), pyrogenic toxin super antigen (PTSAg), haemolysins (hla-hlg), toxic-shock syndrome toxin (tst), enterotoxins (sea-seo, seu), exfoliative toxins (eta, etb), and genes for methicillin (mecA) and penicillin (blaZ) resistance. Attainment of refuge inside the macrophages and neutrophils is a major cause of S. aureus mastitis persistence. Mammary prebiotics and probiotics are recently being used as alternatives to antibiotic for the prevention of mastitis. Literature showed anti- staphylococcus vaccines with different results depending upon types of immunization, route of administration and adjuvant used. Studies has shown that herd specific as well as commercial S. aureus vaccines reduce new infections in dairy animals. Experiments are still in progress for the use of vaccines against S. aureus mastitis with optimal efficacy and reliability. Perhaps, there might be bright future because of highly satisfactory trial results of mastitis vaccines in the lab animals.
金黄色葡萄球菌和乳突
金黄色葡萄球菌是乳动物乳腺内感染的主要病原体,具有表面成分、毒素和细胞外酶的潜在毒力。金黄色葡萄球菌在牛乳房的患病率约为74%,在奶牛的总体患病率超过61%。据报道,大约有17种不同血清型的乳源金黄色葡萄球菌含有24个毒力编码基因,分别为杀白细胞素(lukED/lukM)、热原毒素超抗原(PTSAg)、溶血素(hla-hlg)、中休克综合征毒素(tst)、肠毒素(sea-seo、seu)、剥脱性毒素(eta、ethb)以及甲氧西林(mecA)和青霉素(blaZ)抗性基因。在巨噬细胞和中性粒细胞内获得庇护是金黄色葡萄球菌乳腺炎持续存在的主要原因。乳房益生元和益生菌最近被用作抗生素预防乳腺炎的替代品。文献显示抗葡萄球菌疫苗因免疫类型、给药途径和佐剂的使用而有不同的结果。研究表明,畜群特异性以及商业化的金黄色葡萄球菌疫苗减少了奶牛的新感染。使用具有最佳疗效和可靠性的金黄色葡萄球菌乳腺炎疫苗的实验仍在进行中。也许,乳腺炎疫苗在实验动物上的试验结果令人非常满意,这将有一个光明的前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信